MGRC Healthcare and PPASM Unite for Miss International Malaysia 2023

Advancing Health Awareness with Entertainment, Arts, and Biopharmaceutical Innovation

PETALING JAYA (11 SEPTEMBER 2023) – Malaysian Genomics Resource Centre Berhad (“Malaysian Genomics” or “the Group”), a leading genomics and biopharmaceutical specialist, is thrilled to announce a Strategic Collaboration Agreement with Persatuan Pentas Anak Seni Malaysia ("PPASM").

The partnership, spotlighted at the upcoming Miss International Malaysia 2023 National Grand Final on 1st October, fuses entertainment, arts, and culture with cutting-edge biopharmaceutical technologies like immunotherapy, CAR-T cells and Natural Killer (NK) cells, as well as MGRCH’s cosmeceutical products such as hair serum, moisturisers and face wash under their brand Rejuvium.

PPASM will manage organisational aspects, including approvals and permits, while MGRCH contributes its top-tier expertise in immunotherapy and cell therapies. The collaboration aims not only to promote health awareness but also to foster an environment where individuals are empowered to make informed health decisions.

Azri Azerai, Executive Chairman of Malaysian Genomics, enthused, "Our alliance with PPASM offers a powerful blend of cultural outreach and advanced biopharmaceuticals, empowering Malaysians to take charge of their health. Investors should recognize this collaboration as a broadening of our market scope and a reiteration of our commitment to innovative healthcare solutions."

Jawed Hussain Bin Datuk Raman Wahid, President/National Director of PPASM, said, “In this line of work, we will need to always be in the best shape to give the best of ourselves in our work and to the audience. Working together with MGRC we can learn more about not just our health, but preventive healthcare as well.”

The partnership will kick off with both parties taking an active role in organising educational and promotional events. These include but are not limited to online and offline campaigns that will benefit from the unique strengths of each partner. PPASM’s connections in the arts and culture sector combined with MGRCH’s scientific proficiency are expected to amplify the reach and impact of these health awareness campaigns.

The collaboration also has a charitable aspect, with net proceeds from the Miss International Malaysia 2023 event going to CSR initiatives such as Sandakan Break Cancer Support Association, Kinabalu Pink Ribbon, and the Meraki Daat Sabah Initiative. This move ensures that the collaboration is not just beneficial in raising awareness and educating the public, but also has a tangible impact on charitable organisations working in similar domains.

In the spirit of September being Blood Cancer Awareness month, MGRCH also recently collaborated with Yayasan Kanser Malaysia (“YKM”) to elevate cancer awareness and the importance of early detection within the community by utilising MGRCH’s advanced genomic and immunotherapy service, including cutting-edge CAR-T cells and Natural Killer (NK) cells.

As of 8 September 2023, MGRC’s share price was at RM0.485, with a market capitalisation of RM66.55 million.